ALX Oncology Holdings Inc. (NASDAQ:ALXO) Q3 2025 Earnings Call Transcript November 7, 2025
ALX Oncology Holdings Inc. misses on earnings expectations. Reported EPS is $-0.41 EPS, expectations were $-0.37.
Jason Lettmann: Thanks, everyone, and welcome to our Q3 2025 results. I appreciate everybody spending some time with us this morning, and I’m looking forward to this update. On Slide 2 here before we start our presentation of housekeeping here are our forward-looking statements for your...
